| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals | |
| #3 | Foods and drinks | |
| #4 | Environmental technology | |
| #5 | IT methods for management |
| # | Technology | |
|---|---|---|
| #1 | Microorganisms | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Peptides | |
| #5 | Enzymes | |
| #6 | Climate change adaptation technologies | |
| #7 | Measuring microorganism processes | |
| #8 | Data processing systems |
| # | Name | Total Patents |
|---|---|---|
| #1 | Jantz Derek | 26 |
| #2 | Smith James Jefferson | 22 |
| #3 | Nicholson Michael G | 12 |
| #4 | Bartsevich Victor | 10 |
| #5 | Macleod Daniel T | 6 |
| #6 | Martin Aaron | 4 |
| #7 | Antony Jeyaraj | 4 |
| #8 | Beard Clayton | 3 |
| #9 | Lape Janel | 3 |
| #10 | Smith James | 3 |
| Publication | Filing date | Title |
|---|---|---|
| AU2017338846A1 | Co-stimulatory domains for use in genetically-modified cells | |
| AU2015229299A1 | Dystrophin gene exon deletion using engineered nucleases | |
| AU2015201270A1 | Rationally-designed single-chain meganucleases with non-palindromic recognition sequences | |
| AU2009271011A1 | Recognition sequences for I-Crei-derived meganucleases and uses thereof |